Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livia Ferrari

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|August 30, 2022
Tackling recalcitrant Pseudomonas aeruginosa infections in critical illness via anti-virulence monotherapyVijay K Singh, Marianna Almpani, Damien Maura, et al.
Virulence|October 20, 2022
Targeting virulence regulation to disarm <i>Acinetobacter baumannii</i> pathogenesisVincent Trebosc, Valentina Lucchini, Mohit Narwal, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2009
The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feeding in rats as a measure of emetogenicityT Gregg Davis, John J Peterson, Jen-Pyng Kou, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|August 30, 2022
Tackling recalcitrant Pseudomonas aeruginosa infections in critical illness via anti-virulence monotherapyVijay K Singh, Marianna Almpani, Damien Maura, et al.
Virulence|October 20, 2022
Targeting virulence regulation to disarm <i>Acinetobacter baumannii</i> pathogenesisVincent Trebosc, Valentina Lucchini, Mohit Narwal, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2009
The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feeding in rats as a measure of emetogenicityT Gregg Davis, John J Peterson, Jen-Pyng Kou, et al.
Pageof 2